Cargando…

Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone

PURPOSE: Injectable hyaluronic acid-based fillers are commonly used for the correction of skin contour irregularities and to smooth skin depressions formed by volume loss during the aging process. These fillers are particularly efficient to restore perioral skin depressions/wrinkles or to correct to...

Descripción completa

Detalles Bibliográficos
Autores principales: David, Michel, Braccini, Frederic, Garcia, Philippe, Loreto, Frederic, Benadiba, Laurent, Gorj, Mihai, Grand-Vincent, Anne, Rumyantseva Mathey, Elena, Deutsch, Jean-Jacques, Ehlinger, Agnès, Cartier, Hugues, Nadra, Karim, Fanian, Ferial
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351526/
https://www.ncbi.nlm.nih.gov/pubmed/37465030
http://dx.doi.org/10.2147/CCID.S395353
_version_ 1785074350195474432
author David, Michel
Braccini, Frederic
Garcia, Philippe
Loreto, Frederic
Benadiba, Laurent
Gorj, Mihai
Grand-Vincent, Anne
Rumyantseva Mathey, Elena
Deutsch, Jean-Jacques
Ehlinger, Agnès
Cartier, Hugues
Nadra, Karim
Fanian, Ferial
author_facet David, Michel
Braccini, Frederic
Garcia, Philippe
Loreto, Frederic
Benadiba, Laurent
Gorj, Mihai
Grand-Vincent, Anne
Rumyantseva Mathey, Elena
Deutsch, Jean-Jacques
Ehlinger, Agnès
Cartier, Hugues
Nadra, Karim
Fanian, Ferial
author_sort David, Michel
collection PubMed
description PURPOSE: Injectable hyaluronic acid-based fillers are commonly used for the correction of skin contour irregularities and to smooth skin depressions formed by volume loss during the aging process. These fillers are particularly efficient to restore perioral skin depressions/wrinkles or to correct topographical anomalies. The European directives require a continuous evaluation of the performance of these medical devices, particularly for CE marked products. METHODS: An 18-month prospective randomized single-blind study for the efficacy and safety of ART FILLER Universal (AFU) was performed on the lips, the nasolabial folds, and the marionettes lines. The evaluations were performed on 153 subjects enrolled in this study. The efficacy, the longevity, and the safety were evaluated for the injected areas via area specific clinical scoring after a single injection with the filler and with no re-touch. RESULTS: We showed here that filler injection induced potent improvements of volume restoration after a single injection on all the treated areas. These beneficial properties of the filler were significant 3 weeks after injection and during the whole study period. Moreover, injections of the filler were well tolerated by the subjects. The recorded adverse events are routinely seen with HA fillers for face volume corrections, and most of these local reactions resolved within 14 days. CONCLUSION: AFU was well tolerated and showed a continuous efficacy for at least 18 months, in exploratory analyses.
format Online
Article
Text
id pubmed-10351526
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-103515262023-07-18 Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone David, Michel Braccini, Frederic Garcia, Philippe Loreto, Frederic Benadiba, Laurent Gorj, Mihai Grand-Vincent, Anne Rumyantseva Mathey, Elena Deutsch, Jean-Jacques Ehlinger, Agnès Cartier, Hugues Nadra, Karim Fanian, Ferial Clin Cosmet Investig Dermatol Clinical Trial Report PURPOSE: Injectable hyaluronic acid-based fillers are commonly used for the correction of skin contour irregularities and to smooth skin depressions formed by volume loss during the aging process. These fillers are particularly efficient to restore perioral skin depressions/wrinkles or to correct topographical anomalies. The European directives require a continuous evaluation of the performance of these medical devices, particularly for CE marked products. METHODS: An 18-month prospective randomized single-blind study for the efficacy and safety of ART FILLER Universal (AFU) was performed on the lips, the nasolabial folds, and the marionettes lines. The evaluations were performed on 153 subjects enrolled in this study. The efficacy, the longevity, and the safety were evaluated for the injected areas via area specific clinical scoring after a single injection with the filler and with no re-touch. RESULTS: We showed here that filler injection induced potent improvements of volume restoration after a single injection on all the treated areas. These beneficial properties of the filler were significant 3 weeks after injection and during the whole study period. Moreover, injections of the filler were well tolerated by the subjects. The recorded adverse events are routinely seen with HA fillers for face volume corrections, and most of these local reactions resolved within 14 days. CONCLUSION: AFU was well tolerated and showed a continuous efficacy for at least 18 months, in exploratory analyses. Dove 2023-07-13 /pmc/articles/PMC10351526/ /pubmed/37465030 http://dx.doi.org/10.2147/CCID.S395353 Text en © 2023 David et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Clinical Trial Report
David, Michel
Braccini, Frederic
Garcia, Philippe
Loreto, Frederic
Benadiba, Laurent
Gorj, Mihai
Grand-Vincent, Anne
Rumyantseva Mathey, Elena
Deutsch, Jean-Jacques
Ehlinger, Agnès
Cartier, Hugues
Nadra, Karim
Fanian, Ferial
Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone
title Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone
title_full Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone
title_fullStr Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone
title_full_unstemmed Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone
title_short Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone
title_sort long-term efficacy and tolerability of a medium g’ ha filler with tri-hyal technology on the rejuvenation of the mobile facial zone
topic Clinical Trial Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351526/
https://www.ncbi.nlm.nih.gov/pubmed/37465030
http://dx.doi.org/10.2147/CCID.S395353
work_keys_str_mv AT davidmichel longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone
AT braccinifrederic longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone
AT garciaphilippe longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone
AT loretofrederic longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone
AT benadibalaurent longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone
AT gorjmihai longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone
AT grandvincentanne longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone
AT rumyantsevamatheyelena longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone
AT deutschjeanjacques longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone
AT ehlingeragnes longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone
AT cartierhugues longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone
AT nadrakarim longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone
AT fanianferial longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone